Resverlogix is a biotechnology company that researches, develops and commercializes BET inhibitors for the treatment of chronic diseases.
Business Model:
Revenue: $3.2M
Employees: 11-50
Address: 300, 4820 Richard Road SW
City: Calgary
State: alberta
Zip: T3E 6L1
Country: CA
Resverlogix is a biotechnology company that researches, develops and commercializes BET inhibitors for the treatment of chronic diseases.
Contact Phone:
+14032549252
Contact Email:
Listed Exchange:
TMX Group - Toronto Stock Exchange
IPO Date:
10/19/2001
Ticker Symbol:
RVX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2014 | Post-IPO Equity | $2.3M | 5/2021 | Post-IPO Debt | 1 | $6M |
Hepalink Hepalink |
6/2017 | Post-IPO Equity | $10M | 7/2014 | Post-IPO Debt | 1 | $30M |
Citibank Citibank |
3/2010 | Post-IPO Equity | 1 | $25M |
Yorkville Advisors Yorkville Advisors Yorkville Advisors Yorkville Advisors |
4/2019 | Post-IPO Equity | $16.4M | 5/2018 | Post-IPO Debt | $30M | 6/2018 | Post-IPO Equity | 1 | $10.4M |
EFung Capital EFung Capital |
8/2013 | Post-IPO Equity | $1.6M | 12/2011 | Post-IPO Equity | $1.8M | 8/2018 | Private Placement | $20M | 11/2018 | Private Placement | $10.3M | 8/2020 | Private Placement | $2M | 1/2019 | Private Placement | $5M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|